Jia X. Yu
Shanghai, 200065, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 31, 2025
Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study.
Journal: Signal transduction and targeted therapy
Published: August 25, 2025
Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: July 10, 2025
Ensemble learning on serum metabolic fingerprints for early detection of lung adenocarcinoma.
Journal: NPJ precision oncology
Published: June 26, 2025
Correction: Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity.
Journal: Molecular cancer
Published: June 23, 2025
Stromal-Derived IL-8 Promotes M2 Macrophage Polarization via the RhoA/MRTF-A/SRF Transcriptional Axis to Impair CD8+ T Cell Cytotoxicity in Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 03, 2025
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: April 03, 2025
BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma.
Journal: Journal of thoracic disease
Published: February 03, 2025
Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity.
Journal: Molecular cancer
Published: October 22, 2024
Last Updated: 09/26/2026